These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28538919)

  • 21. Scaling-up treatment for HIV/AIDS: lessons learned from multidrug-resistant tuberculosis.
    Gupta R; Irwin A; Raviglione MC; Kim JY
    Lancet; 2004 Jan; 363(9405):320-4. PubMed ID: 14751708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Out of Africa: Uganda and UNAIDS advance a bold experiment.
    Zuniga J
    J Int Assoc Physicians AIDS Care; 1999 Oct; 5(10):48-60. PubMed ID: 11366872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Health policies in Brazil in the 2000s: the national priority agenda].
    Machado CV; Baptista TW; Nogueira Cde O
    Cad Saude Publica; 2011 Mar; 27(3):521-32. PubMed ID: 21519702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretroviral treatment in resource-poor settings: the Brazilian experience.
    Teixeira PR; Vitória MA; Barcarolo J
    AIDS; 2004 Jun; 18 Suppl 3():S5-7. PubMed ID: 15322477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crafting AIDS policy in Brazil and Russia: State-civil societal ties, institutionalised morals, and foreign policy aspiration.
    Gómez EJ
    Glob Public Health; 2016 Oct; 11(9):1148-68. PubMed ID: 27564438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
    Cohen J
    Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
    [No Abstract]   [Full Text] [Related]  

  • 27. Production of antiretroviral drugs in middle- and low-income countries.
    Pinheiro Edos S; Brüning K; Macedo MF; Siani AC
    Antivir Ther; 2014; 19 Suppl 3():49-55. PubMed ID: 25310755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next steps against AIDS.
    Nature; 2001 Apr; 410(6832):1009. PubMed ID: 11323620
    [No Abstract]   [Full Text] [Related]  

  • 29. The fine line between education and marketing.
    Proj Inf Perspect; 1999 Sep; (28):1-3. PubMed ID: 11367352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New rules for new drugs: the challenge of AIDS to the regulatory process.
    Edgar H; Rothman DJ
    Milbank Q; 1990; 68(Suppl. 1):111-42. PubMed ID: 11650413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recommendation of GESIDA (AIDS Study Group)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (I)].
    Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Iribarren JA; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P
    Enferm Infecc Microbiol Clin; 2000; 18(7):329-51. PubMed ID: 11109725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [People living with HIV/AIDS and their link with the antiretrovirals provided by the National Programme in Argentina].
    Colautti MA
    Cien Saude Colet; 2012 May; 17(5):1203-13. PubMed ID: 22634813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biotechnology and the new politics of life and death in Brazil: the AIDS model.
    Biehl J
    Princet J Bioeth; 2002; 5():59-74. PubMed ID: 12755106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug companies, UNAIDS make drugs available.
    AIDS Alert; 1998 Jan; 13(1):3. PubMed ID: 11364863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired immunodeficiency syndrome in Brazil.
    Meira DA
    Croat Med J; 2002 Aug; 43(4):475-9. PubMed ID: 12187527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are country reputations for good and bad leadership on AIDS deserved? An exploratory quantitative analysis.
    Nattrass N
    J Public Health (Oxf); 2008 Dec; 30(4):398-406. PubMed ID: 18791202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [HIV infection and AIDS from the health policy viewpoint. Savings and therapy superiority maintained - a contradiction in HIV therapy?].
    MMW Fortschr Med; 2014 Jun; 156 Suppl 1():62-3. PubMed ID: 25026863
    [No Abstract]   [Full Text] [Related]  

  • 38. Brazil's fight against AIDS and its implications for global health governance.
    Wogart JP; Calcagnotto G
    Healthc Q; 2006; 9(1):76-89. PubMed ID: 16548439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative analysis of outpatient costs in HIV treatment programs.
    Sarti FM; Nishijima M; Campino AC; Cyrillo DC
    Rev Assoc Med Bras (1992); 2012; 58(5):561-7. PubMed ID: 23090227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.